Venus Remedies has informed that the Board of Directors of the Company at its meeting held on November 13, 2015, has transacted the agenda item to reconsider the relevant date for preferential issue could not be discussed due to some approvals pending from exchanges.
The above information is a part of company’s filings submitted to BSE.